Evidence map›Paper›PMID 24938746›Full record

ArticleMucosal immunology2015

CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection.

J M Moore-Connors, H S Kim, J S Marshall, A W Stadnyk, S A Halperin, J Wang

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Induction of IL-10-producing regulatory B cells followingBiochemistry and biophysics reports · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

J M Moore-Connors1] Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada [2] Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
H S Kim1] Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada [2] Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
J S MarshallDepartment of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
A W Stadnyk1] Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada [2] Faculty of Medicine, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada [3] IWK Health Centre, Halifax, Nova Scotia, Canada B3K 6R8.
S A Halperin1] Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada [2] Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada [3] Faculty of Medicine, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada [4] IWK Health Centre, Halifax, Nova Scotia, Canada B3K 6R8.
J Wang1] Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada [2] Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada [3] Faculty of Medicine, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada [4] IWK Health Centre, Halifax, Nova Scotia, Canada B3K 6R8.
Dalhousie University · CAIzaak Walton Killam Health Centre · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Regulatory B (Breg) cells are known to modulate immune responses through predominantly interleukin-10 (IL-10)-dependent mechanisms and can be hypothetically divided into innate and adaptive subsets based on the nature of their activating signals. However, the specific role of different Breg subsets in modulating immune responses remains ambiguous. Here we have shown that Chlamydia induces IL-10-producing splenic B-cell populations consisting of CD43(+) and CD43(-) subsets of IgM(hi)IgD(lo) innate-like B (ILB) cells in vitro. While CD43(+)IL-10-producing B cells displayed innate type features and were readily induced by Chlamydia via Toll-like-receptor (TLR) signaling, CD43(-)IL-10-producing B cells required additional B-cell activating factor (BAFF)-mediated signals from dendritic cells (DCs) for their differentiation and activation, thereby classifying them as adaptive type Bregs. Importantly, CD43(-), but not CD43(+), IL-10-producing ILB cells displayed bona fide Breg activity by potently suppressing interferon-γ (IFN-γ) production in vitro in an IL-10-dependent manner. Furthermore, a novel CD43(-)CD1d(hi)CD5(+) IL-10-producing Breg population was predominantly induced by Chlamydia genital infection in vivo. Correspondingly, mixed bone marrow chimeric mice with B-cell-specific IL-10 deficiency exhibited significantly increased type 1 immune responses, decreased bacterial burden, and reduced oviduct pathology upon infection. Our data demonstrate for the first time a distinct role for CD43(-)CD1d(hi)CD5(+)-adaptive Bregs over CD43(+) innate counterparts in controlling mucosal responses against intracellular bacterial infection.

Indexed as

Adaptive ImmunityAnimalsAntigens, CD1Bacterial LoadB-Cell Activation Factor ReceptorB-Lymphocytes, RegulatoryB-Lymphocyte SubsetsCD5 AntigensCell DifferentiationCells, CulturedChimeraChlamydia InfectionsChlamydia muridarumDendritic CellsGenitaliaImmunity, InnateAntigens, CD1B-Cell Activation Factor ReceptorCD5 AntigensImmunoglobulin mu-ChainsInterleukin-10LeukosialinTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID24938746
OpenAlexW2318848584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.